StemBond Technologies 'one to watch'
Portfolio company StemBond Technologies was recently listed as one to watch
In their 2023 list of 10 Top Regenerative Medicine Startups to Watch, Startus Insights included portfolio company StemBond Technologies.
This is fantastic recognition of the work being done by CEO and Founder Andrew Hodgson and the team as they pursue their mission to make cell therapies highly effective and accessible to all.
StemBond Technologies specialises in advanced materials for cell and tissue culture, giving them the power to influence cell fate and function, resulting in superior cell products at a larger scale.
You can find out more on StemBond Technologies' portfolio page and read more on their Startus listing on the Startus site.